SynthesisRenal failure2025

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization.

Yu-Xuan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.